Rodos biotarget Rodos
Rodos Biotarget develops and commercializes nanocarrier based drugs for the treatment of cancer, chronic infections and neurological disorders.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Rodos biotarget Rodos Information
Geographic Data
Address: Feodor-Lynen-Str. 31
City: Hannover
State: saxony
Zip: 30625
Country: DE
Financial Info
Stage:
equity crowdfunding
Raised Last:
$204k
Raised Total:$941k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Rodos Biotarget develops and commercializes nanocarrier based drugs for the treatment of cancer, chronic infections and neurological disorders.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2017 | Unattributed | $940.7k | 1/2012 | Venture Round | - |
Business Angels Agentur Ruhr Business Angels Agentur Ruhr |
7/2016 | Seed Round | 1 | - |
Christopher Isak Christopher Isak |
8/2017 | Equity Crowdfunding | 1 | $203.8k |
Aescuvest Aescuvest |
4/2013 | Venture Round | 3 | $3.4M |
Enjoyventure Management ERP Startfonds High-Tech Grunderfonds Enjoyventure Management ERP Startfonds High-Tech Grunderfonds |
5/2009 | Seed Round | 1 | - |
High-Tech Grunderfonds High-Tech Grunderfonds |
7/2016 | Seed Round | 1 | - |
Christopher Isak Christopher Isak |
1/2012 | Venture Round | 1 | - |
Business Angels Agentur Ruhr Business Angels Agentur Ruhr |
5/2009 | Seed Round | 1 | - |
High-Tech Grunderfonds High-Tech Grunderfonds |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
